Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: An immunohistochemical study

Medical Oncology

Volumn 28, Issue 3, 2011, Pages 846-851

  Hacıhanefioglu, Abdullah ^a   Gonullu, Emel ^a   Mehtap, Ozgur ^a   Keski, Hakan ^a   Yavuz, Melike ^a   Ercin, Cengiz ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Heat shock protein 90; Immunohistochemical staining; Survival; Vascular endothelial growth factor

Indexed keywords

HEAT SHOCK PROTEIN 90; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 80052481345     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9533-0     Document Type: Article

References (40)

1. FU Hartl M Hayer-Hartl 2002 Molecular chaperones in the cytosol: from nascent chain to folded protein Science 295 1852 1858 11884745 10.1126/science.1068408 1:CAS:528:DC%2BD38XhvFClsL4%3D
2. F Burrows H Zhang A Kamal 2004 Hsp90 activation and cell cycle regulation Cell Cycle 3 1530 1536 15539946 10.4161/cc.3.12.1277 1:CAS:528: DC%2BD28XjtVersbw%3D
3. AS Sreedhar G Nardai P Csermely 2004 Enhancement of complement-induced cell lysis: a novel mechanism for the anticancer effects of HSP90 inhibitors Immunol Lett 92 157 161 15081540 10.1016/j.imlet.2003.11.025 1:CAS:528:DC%2BD2cXjtV2gt7w%3D
4. A Kamal, et al. 2003 A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors Nature 25 407 410 10.1038/nature01913
5. JS Isaacs W Xu L Neckers 2003 Heat shock protein 90 as a molecular target for cancer therapeutics Cancer Cell 3 213 217 12676580 10.1016/S1535-6108(03) 00029-1 1:CAS:528:DC%2BD3sXislOrtb8%3D
6. S Kojika, et al. 1996 Mechanisms of glucocorticoid resistance in human leukemic cells: Implication of abnormal 90 and 70 kDa heat shock proteins Leukemia. 10 994 999 8667658 1:STN:280:DyaK283ms1Gjuw%3D%3D
7. C Garrido, et al. 1997 HSP27 as a mediator of influence- dependent resistance to cell death induced by anticancer drugs Cancer Res 57 2661 2667 9205074 1:CAS:528:DyaK2sXktlSjtr0%3D
8. C Jolly RI Morimoto 2000 Role of the heat shock response and molecular chaperones in oncogenesis and cell death J Natl Cancer Res Inst 92 1564 1572 10.1093/jnci/92.19.1564 1:CAS:528:DC%2BD3cXnsVKitr4%3D
9. A Brozovic S Simaga M Osmak 2001 Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia Neoplasma 48 99 103 11478701 1:CAS:528:DC%2BD3MXktVGrtbY%3D
10. SC Santos S Dias 2004 Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways Blood 103 3883 3889 14726393 10.1182/blood-2003-05-1634 1:CAS:528:DC%2BD2cXjvF2iu7c%3D
11. HP Gerber, et al. 2002 VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism Nature 417 954 958 12087404 10.1038/nature00821 1:CAS:528:DC%2BD38XkvVagsb0%3D
12. S Dias SV Shmelkov G Lam S Rafii 2002 VEGF promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition Blood 99 2532 2540 11895790 10.1182/blood.V99.7.2532 1:CAS:528: DC%2BD38XisFGhsbw%3D
13. A Aguayo F Giles M Albitar 2003 Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes Leuk Lymphoma 44 213 222 12688336 10.1080/1042819021000029777 1:CAS:528:DC%2BD38Xpt1Kqs7k%3D
14. Y Zhang, et al. 2005 Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immuno- histochemical study Hum Pathol 36 797 805 16084950 10.1016/j.humpath. 2005.05.015 1:CAS:528:DC%2BD2MXntVOis7g%3D
15. L Kalmanti, et al. 2005 A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood Leuk Res 29 673 677 15863208 10.1016/j.leukres.2004.08.013
16. A Perez-Atayde, et al. 1997 Spectrum of tumor angiogenesis in the bore marrow of children with acute lymphoblastic leukemia Am J Pathol 150 815 825 9060819 1:STN:280:DyaK2s3hsVCguw%3D%3D
17. I Kuzu, et al. 2004 Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival Leuk Lymphoma 45 1185 1190 15359999 10.1080/1042819032000159915 1:CAS:528: DC%2BD2cXjt1yktrY%3D
18. ES de Bont, et al. 2001 Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor Br J Haematol 113 296 304 11380392 10.1046/j.1365-2141.2001.02722.x
19. W Rabitsch, et al. 2004 Bone marrow microvessel density and its prognostic significance in AML Leuk Lymphoma 45 1369 1373 15359635 10.1080/10428190410001663707
20. Q Yao, et al. 2003 FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases Clin Cancer Res 9 4483 4493 14555522 1:CAS:528:DC%2BD3sXotVShtr0%3D
21. JR Valbuena, et al. 2005 Expression of heat-shock protein-90 in non-Hodgkin's lymphomas Modern Pathology 18 1343 1349 16056252 10.1038/modpathol.3800459 1:CAS:528:DC%2BD2MXhtVWiu7fJ
22. K Xiao W Liu S Qu H Sun J Tang 1996 Study of heat shock protein HSP90 alpha, HSP70, HSP27 mRNA expression in human acute leukemia cells J Tongji Med Univ 16 212 216 9389084 10.1007/BF02888109 1:CAS:528:DyaK1cXmvFOju7o%3D
23. L Campos S Chautard A Viallet D Guyotat 1999 Expression of heat-shock proteins in acute leukaemia cells Haematologica. 84 13
24. M Lauten, et al. 2003 Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia Leukemia 17 1551 1556 12886242 10.1038/sj.leu.2403027 1:CAS:528: DC%2BD3sXlslOitLY%3D
25. MA Biamonte, et al. 2010 heat shock protein 90: inhibitors in clinical trials J Med Chem 53 3 17 20055425 10.1021/jm9004708 1:CAS:528: DC%2BD1MXhtFCjt7vJ
26. L Neckers SP Ivy 2003 Heat shock protein 90 Curr Opin Oncol 15 419 424 14624223 10.1097/00001622-200311000-00003 1:CAS:528:DC%2BD3sXptVCmsbg%3D
27. X Thomas, et al. 2003 Expression of heat-shock proteins (HSPs) is associated with major adverse prognostic factors in acute myeloid leukemia (AML) Blood 102 suppl. 1 611a
28. S Kasimir-Bauer, et al. 2002 Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia Exp Hematol 30 11 1302 1308 12423683 10.1016/S0301-472X(02)00926-8 1:CAS:528:DC%2BD38XosFCjsrc%3D
29. S Molica, et al. 2004 Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression Eur J Haematol 73 36 42 15182336 10.1111/j.1600-0609.2004.00269.x 1:CAS:528:DC%2BD2cXlvF2qsrs%3D
30. S Yetgin I Yenicesu M Çetin M Tuncer 2001 Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia Leuk Lymphoma 42 1-2 83 88 11699225 10.3109/10428190109097679 1:CAS:528:DC%2BD3MXmtVOgsrs%3D
31. S Faderl, et al. 2005 Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia Blood 106 4303 4307 16123221 10.1182/blood-2005-03-1010 1:CAS:528:DC%2BD2MXhtlaltrvI
32. JG Kim, et al. 2005 Clinical implication of angiogenic factors in patients with: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia Leuk Lymphoma 46 885 891 16019534 10.1080/10428190500054491
33. WT Bellamy L Richter Y Frutiger TM Grogan 1999 Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies Cancer Res 59 728 733 9973224 1:CAS:528:DyaK1MXhtFSitr8%3D
34. A Aguayo, et al. 2000 Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia Blood 96 768 770 10887147 1:CAS:528:DC%2BD3cXltVGgs74%3D
35. A El-Obeid N Sunnuqrut A Hussain, et al. 2004 Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR) Leuk Res 28 133 137 14654077 10.1016/S0145-2126(03)00188-7 1:CAS:528:DC%2BD3sXptl2qs7w%3D
36. R Koomagi F Zintl A Sauerbrey M Volm 2001 Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction Clin Cancer Res 7 3381 3384 11705851 1:CAS:528:DC%2BD3MXptFaju7Y%3D
37. CJ Lyu SY Rha SC Won 2007 Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia Yonsei Med J 48 171 175 17461513 10.3349/ymj.2007.48.2.171 1:CAS:528:DC%2BD2sXmtFKgtbc%3D
38. E Diffner, et al. 2009 Expression of VEGF and VEGF receptors in childhood precursor B-cell acute lymphoblastic leukemia evaluated by immunohistochemistry J Pediatr Hematol Oncol 31 696 701 19707156 10.1097/MPH.0b013e3181b258df
39. P Schneider, et al. 2007 Endostatin variations in childhood acute lymphoblastic leukaemia-comparison with basic fibroblast growth factor and vascular endothelial growth factor Leuk Res 31 629 638 17011029 10.1016/j.leukres.2006.08.023 1:CAS:528:DC%2BD2sXkt1aqsbo%3D
40. S Aref O Salama S Shamaa M El-Refaie H Mourkos 2007 Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia Hematology 12 319 324 17654059 10.1080/10245330701340759 1:CAS:528: DC%2BD2sXotFajsr8%3D